In announcing its acquisition of rival Wyeth--based on the other side of the Hudson River in Madison, NJ--Pfizer on Monday also provided details of a new cost-reduction initiative. As part of the initiative, Pfizer says it will reduce its global workforce by approximately 10%, or approximately 8,000 jobs. Reductions will span sales, manufacturing, research and development and administrative organizations, Pfizer states.
The company also intends to reduce the number of manufacturing sites from the current 46 to 41, as well as reduce its facilities square footage by approximately 15%, according to a release. During a news conference Monday at Pfizer's world headquarters, 235 E. 42nd St., Pfizer officials declined to identify where plant closings would occur, and a Pfizer spokesman did not respond to GlobeSt.com's requests for further comment.
It's too early to judge what the consolidation of the two companies means in terms of office space, CresaPartners' Robert Stella tells GlobeSt.com. "They're going to have some Wyeth people here" in Midtown, says Stella, EVP and principal with the tenant-rep firm. "How many is hard to say."
Recommended For You
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.